117 results
POS AM
ABVC
ABVC BioPharma Inc
25 Apr 24
Prospectus update (post-effective amendment)
2:38pm
for hedging, trading or speculative purposes.
We perform ongoing credit evaluation of our customers and requires no collateral. An allowance … with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible
424B4
ABVC
ABVC BioPharma Inc
5 Apr 24
Prospectus supplement with pricing info
2:47pm
Insurance Corporation’s insurance limits. The Company does not enter into financial instruments for hedging, trading or speculative purposes.
We … ) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity
DEFA14A
ABVC
ABVC BioPharma Inc
25 Mar 24
Additional proxy soliciting materials
4:30pm
. Federal Deposit Insurance Corporation’s insurance limits. The Company does not enter into financial instruments for hedging, trading or speculative … 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts
8-K/A
EX-99.1
x539pvwx2 2caspqmmbv
26 Jan 24
Report of Independent Registered Public Accounting Firm
12:00am
8-K
EX-10.2
odg7ljx
17 Jan 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.2
ye7wtpd1c0bpugifb 1d
20 Nov 23
Entry into a Material Definitive Agreement
8:30am
424B4
nwn8s0uif we
17 Nov 23
Prospectus supplement with pricing info
5:00pm
424B4
j93a83jt4k
17 Nov 23
Prospectus supplement with pricing info
5:00pm
424B3
6rmmja77f40sdk 9ca
17 Nov 23
Prospectus supplement
5:00pm
424B4
0io3n 14n
17 Aug 23
Prospectus supplement with pricing info
5:00pm
424B4
zbs2f lmk7
17 Aug 23
Prospectus supplement with pricing info
5:00pm